Nicotine-induced upregulation of antioxidant protein Prx 1 in oral squamous cell carcinoma by unknown
   
 
© The Author(s) 2013. This article is published with open access at Springerlink.com csb.scichina.com   www.springer.com/scp 
                      
*Corresponding author (email: xftang10@yahoo.com) 
Article 
Preclinical Medicine June 2013  Vol.58  No.16: 19121918 
 doi: 10.1007/s11434-013-5779-1 
Nicotine-induced upregulation of antioxidant protein Prx 1 in oral 
squamous cell carcinoma 
ZHAO YanHua1, ZHANG Min1, YAN Fei2, CASTO Bruce C3 & TANG XiaoFei1* 
1 Division of Oral Pathology, Beijing Institute of Dental Research, School of Stomatology, Capital Medical University, Beijing 100050, China;  
2 Division of Medical Oncology, Department of Internal Medicine, Ohio State University College of Medicine and Comprehensive Cancer Center, 
Columbus, OH 43210, USA; 
3 Division of Environmental Health Sciences, Ohio State University College of Public Health, Columbus, OH 43210, USA  
Received November 29, 2012; accepted January 8, 2013; published online March 26, 2013 
 
Nicotine is a source of exogenous oxidative stress, which is associated with the pathogenesis of numerous diseases including oral 
squamous cell carcinoma (OSCC), whereas an antioxidant protein, peroxiredoxin 1 (Prx 1), plays an important role in the modula-
tion of this condition. This study was to investigate the association between Prx 1 and tobacco-induced oxidative stress. The ex-
pression of Prx 1 and GST  in OSCC Tca8113 cells, which were pre-treated with nicotine, was determined. In the present study, 
MTT assay, reactive oxygen species (ROS) assay, RT-PCR and Western blot analyses, respectively, were conducted to assess cell 
viability, ROS level, and expression level of Prx 1 and GST  in nicotine-treated Tca8113 cells. Nuclear factor kappa B (NF-B) 
expression was detected by immuno-fluorescence. Our results showed the growth of Tca8113 cells was increased in a dose-dependent 
manner when cells were treated with nicotine at concentrations from 0.1 to 10 mol/L, but the proliferation of the cells decreased 
at 100 mol/L. ROS levels increased in all groups treated with nicotine at concentrations of 0.1, 1, 10, or 100 mol/L for 24 h. 
Prx 1 and GST  mRNA and protein expression were up-regulated in cells treated with nicotine for the same time at different 
concentrations or at the same concentration for different times (P<0.05). NF-B was translocated from cytoplasm to nucleus, the 
expression of NF-B was increased in nucleus. These results suggest that up-regulation of Prx1 expression appears to be associ-
ated with tobacco-induced oxidative stress, which may play an important role in the pathogenesis of OSCC.  
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Oral squamous cell carcinoma (OSCC) is one of the most 
common malignant neoplasms worldwide [1]. The annual 
death toll for OSCC has increased rapidly, which may be 
due to the fact that most OSCC cases are diagnosed at a 
later stage presumably due to the lack of reliable early di-
agnostic markers [2]. Detection of OSCC is presently based 
on clinical examination and subsequent histological analysis 
of suspicious biopsies, but some minor lesions may be un-
detectable in hidden sites. Therefore, identification of sensi-
tive and specific biomarkers for OSCC could be helpful for 
early diagnosis and serve as a screening method in high-risk 
populations [3]. 
Risk factors for OSCC include tobacco use, alcohol con-
sumption, nutritional deficiency, marijuana use, and expo-
sure to human papilloma and Epstein-Barr viruses. Among 
all OSCC cases, about 75% of cases are linked with tobacco 
use and alcohol consumption, tobacco, by far, is the major 
risk factor for OSCC [4,5]. Nicotine is one of the most im-
portant components in tobacco, which increases the levels 
of reactive oxygen species (ROS) in both oral normal mu-
cosal and cancer epithelial cells [6,7]. Excess ROS induces 
oxidative stress, cellular damage, and ultimately, malignant 
transformation.  
Peroxiredoxins (Prx, E.C. 1.11.1.15) are thiol-dependent 
antioxidant proteins. They are found in a wide variety of 
species and play a critical role in peroxide detoxification [8]. 
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Prx 1 is a multifunctional 2-Cys peroxiredoxin family mem-
ber and is overly expressed in numerous cancers including 
OSCC [9–11]. However, Prx 1 expression and tobacco-in-     
duced oxidative stress have not been elucidated in OSCC. 
GST  is a marker protein in many cancers and high levels 
are linked to drug resistance. S-glutathionylation of proteins 
is critical to cellular stress response and GST  potentiates 
S-glutathionylation reactions following oxidative stress in 
vitro and in vivo. GST  could conjugate glutathione to a 
member of the peroxiredoxin family, including Prx 1 [12].  
In our previous investigations, we found that Prx1 and 
GST  both were up-regulated in the OSCC cell line, 
Tca8113, when compared to the oral precancerous cell line, 
DOK, by DNA microarray [13]. We hypothesized that nico-
tine treatment would influence cell proliferation, ROS levels, 
and Prx1 and GST  expression in an OSCC cell line 
(Tca8113). In the current study, we evaluated these bi-
omarkers in a nicotine-induced OSCC. 
1  Materials and methods  
1.1  Cell culture 
The Tca8113 human OSCC cell line was obtained from the 
School of Stomatology, Peking University, Beijing, China. 
Cells were cultured in RPMI1640 supplemented with 10% 
FBS, 100 units/mL penicillin, and 100 g/mL streptomycin 
at 37°C, in a 5% CO2 humidified chamber. 
1.2  MTT assay 
2.5×104 cells were seeded in a 96-well plate and incubated 
overnight for cell attachment. Cells were treated with 0.1, 1, 
10 or 100 mol/L nicotine (Wako, Japan) for 24, 48 or 72 h. 
After treatment, 20 L of MTT solution (5 mg/mL in PBS) 
(MTT, Sigma, USA) were added to each well and incubated 
for 4 h. The medium was removed and 150 L DMSO was 
added to each well. The formazan dye crystals were solu-
bilized for 10 min, and absorbance was then measured by 
colorimetric assay (TECAN, Austria). The MTT assay was 
based on the cleavage of the yellow tetrazolium salt MTT to 
purple formazan crystal by metabolically active cells. The 
formazan was then solubilized, and the concentration was 
determined by optical density at 570 nm [14]. 
1.3  ROS assay 
ROS was measured by a cell-permeable fluorogenic probe 
2,7-dichlorfluorescein-diacetate (DCFH-DA) described by 
Rajendra et al. [15]. Briefly, Tca8113 cells (1×105) were 
treated with nicotine (0.1, 1, 10, 100 mol/L) for 24 h in a 
24 well plate. Then, 2.5 mol/L DCFH-DA (Puli Lai Com-
pany, China) was added to each well and incubated for 30 
min. DCFH-DA was diffused into cells and deacetylated by 
cellular esterases to nonfluorescent 2,7-dichlorodihydroflu-      
orescin (DCFH), which was rapidly oxidized to highly fluo-
rescent 2,7-dichlorodihydrofluorescein (DCF) by ROS. The 
samples were analyzed by flow cytometry (Coulter Epics®-     
XL, Beckman, USA) in three separate experiments using 
excitation and emission wavelengths of 480 nm and 530 nm, 
respectively. 
1.4  RT-PCR analysis 
Tca8113 cell lines were treated with 0.1, 1, 10 or 100 
mol/L nicotine for 48 h, or 1 mol/L for 24, 48 or 72 h. 
Total RNA was extracted using TRIzol Reagent (Promega, 
USA) from nicotine-untreated and nicotine-treated cells 
according to the manufacturer’s instructions. RT-PCR was 
then performed as previously described [16]. The sequences 
of primers were as follows: Prx 1: Sense: 5′-ATGTCTTCAG-     
GAAATGCTAAAAT-3′, antisense: 5′-TCACTTCTGCTTG-     
GAGAAATATTC-3'; GST: Sense: 5'-CAGGAGGGCTCA-      
CTCAAA-3′, antisense: 5′-GATCAGCAGCAAGTCCAGC-    
AG-3′; -actin: Sense: 5′-AGCGAGCATCCCCCAAAGTT- 
3′, antisense: 5′-GGGCACGAAGGCTCATCATT-3′ (Aoke, 
China).  
1.5  Western blot analysis 
Tca8113 cell lines were treated with nicotine, and whole- 
cell lysates were prepared from treated and untreated con-
trol cells. Protein concentration was determined using the 
Bradford reagent. Equal amounts of protein extracts were 
analyzed in duplicate by SDS-PAGE. Prx1 polyclonal anti-
body (1:2000, Abcam, USA), GST  polyclonal antibody 
(1:200, ZSGB-BIO, China) and a monoclonal antibody against 
-actin (1:2000, Santa Cruz, USA). Protein level was de-
tected by an ECL Test Kit and visualized by autoradiog-
raphy. For normalization of protein loading, the membranes 
were stripped using stripping buffer and prepared for West-
ern blot analysis with -actin antibody as a reference. 
1.6  Immuno-fluorescence 
Tca8113 cells plated at glass coverslips and treated with   
1 mol/L nicotine for 24, 48 or 72 h, were washed twice 
with PBS, and fixed with ice-cold 4% paraformaldehyde for 
10 min. After blocking using 10% goat serum for 30 min, 
the cells were incubated with rabbit monoclonal anti-NF- 
B primary antibodies (1:100, Abcam, USA) at 37°C for 1 h, 
washed 5 times in PBS, stained with conjugated secondary 
antibody for 1 h at room temperature in dark, washed 5 times 
for 5 min with PBS, mount coverslip with anti-fading agent. 
1.7  Statistical analysis 
Data are presented as means±standard deviation (SD). Two 
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independent T tests were used to assess differences between 
control and treated cells. A probability level of P<0.05 was 
considered statistically significant. The analyses were per-
formed with SPSS Software for Windows 11.5. 
2  Results 
2.1  MTT assay  
As shown in Figure 1, the proliferation of Tca8113 cells was 
increased after treatment with 0.1, 1 or 10 μmol/L nicotine 
for 24 or 48 h (P<0.05). However, cell proliferation was 
reduced after treatment with 100 μmol/L nicotine for 72 h 
(P<0.05).  
2.2  ROS assay 
ROS was significantly increased in cells treated with 0.1, 1, 
10, or 100 μmol/L nicotine for 24 h (Figure 2) compared 
with the untreated cells (P<0.05).  
2.3  RT-PCR analysis  
The mRNA expression levels of Prx 1 in Tca8113 cells 
were shown to be significantly increased by 1.05-fold (P< 
0.05), 1.1-fold (P<0.05), 1.1-fold (P<0.05) and 1.1-fold (P< 
0.05) in cells treated with 0.1, 1, 10 or 100 μmol/L nicotine, 
respectively, for 48 h, when compared to nicotine-untreated 
cells (Figure 3(a)). The expression level of Prx 1 in cells 
treated with 1 μmol/L nicotine for 24, 48 or 72 h was de-
termined. Prx 1 was significantly up-regulated after 48 and 
72 h treatment (P<0.05), but not 24 h treatment when com-
pared to untreated cells (Figure 3(b)). The mRNA expres-
sion levels of GST  were shown to be significantly in-
creased by 1.1-fold (P<0.05), 1.1-fold (P<0.05), 1.1-fold 
(P<0.05) in cells treated with 0.1, 1, 10 mol/L nicotine, 
respectively, for 48 h, when compared to nicotine-untreated 
cells (Figure 4(a)). The expression level of GST  was sig-
nificantly up-regulated (P<0.05) in Tca8113 cells treated 
with 1 μmol/L nicotine for 24, 48 or 72 h when compared to 
untreated cells (Figure 4(b)).  
 
Figure 1  Effects of nicotine on Tca8113 cells. Viability was measured by MTT assay. Columns: average of three independent experiments; error bars: 
±SD; using a two-tailed Student’s t-test, * P<0.05 versus untreated cells.  
 
Figure 2  ROS levels detected in Tca8113 cells treated with nicotine for 24 h. Columns: average of three independent experiments; error bars: ±SD; using a 
two-tailed Student’s t-test, * P<0.05 versus untreated cells.  
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Figure 3  Prx 1 mRNA expression assessed by RT-PCR in Tca8113 cells treated with 0.1, 1, 10 or 100 mol/L nicotine for 48 h (a) and 1 mol/L nicotine 
for 24, 48 or 72 h (b). Columns: average of three independent experiments; error bars: ±SD; using two-tailed Student’s t-test, * P<0.05 versus control group.  
2.4  Western blot analysis  
As depicted in Figure 5(a), the protein expression levels of 
Prx 1 in Tca8113 cells were significantly increased by 1.3- 
fold (P<0.05), 1.8-fold (P<0.05), 2.5-fold (P<0.05) and 
2.6-fold (P<0.05) in cells treated with 0.1, 1, 10 or 100 
μmol/L nicotine, respectively, for 48 h, when compared to 
nicotine-untreated cells. The protein expression of Prx 1 in  
cells treated with 1 μmol/L nicotine for 24, 48 and 72 h was 
also evaluated. The data show that Prx 1 was significantly 
increased by 1.4-fold, 1.6-fold and 2.0-fold at 24, 48 and 72 
h, respectively, when compared to nicotine-untreated cells 
(P<0.05, Figure 5(b)).  
The protein expression levels of GST  were significantly 
increased by 1.1-fold (P<0.05), 1.3-fold (P<0.05), 1.2-fold  
 
Figure 4  GST  mRNA expression assessed by RT-PCR in Tca8113 cells treated with 0.1, 1, 10 or 100 mol/L nicotine for 48 h (a) and 1 mol/L nicotine 
for 24, 48 or 72 h (b). Columns: average of three independent experiments; error bars: ±SD; using two-tailed Student’s t-test, * P<0.05 versus control group. 
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Figure 5  Prx 1 protein expression evaluated by Western blot in Tca8113 cells treated with 0.1, 1, 10 or 100 mol/L nicotine for 48 h (a) and 1 μmol/L 
nicotine for 24, 48 or 72 h (b). Membranes were stripped and reprobed with -actin as a control. Similar results were obtained from three independent ex-
periments. Columns: mean relative densitometric intensities; error bars: ±SD; using two-tailed Student’s t-test, * P<0.05 versus control group.  
(P<0.05) and 1.5-fold (P<0.05) in cells treated with 0.1, 1, 
10 or 100 μmol/L nicotine, respectively, for 48 h, when 
compared to nicotine-untreated cells (Figure 6(a)). The data 
show that the protein expression of GST  in cells treated 
with 1 mol/L nicotine for 24, 48 and 72 h was signifi-
cantly increased by 1.1-fold, 1.3-fold and 1.8-fold, respec-
tively, when compared to nicotine-untreated cells (P<0.05, 
Figure 6(b)).  
2.5  Immuno-fluorescence 
As shown in Figure 7, NF-B expression in the nucleus 
treated with 1 μmol/L nicotine for 24, 48 and 72 h were 
increased significantly in Tca8113 cells compared to nicotine- 
 
Figure 6  GST  protein expression evaluated by Western blot in Tca8113 cells treated with 0.1, 1, 10 or 100 mol/L nicotine for 48 h (a) and 1 mol/L 
nicotine for 24, 48 or 72 h (b). Membranes were stripped and reprobed with -actin as a control. Similar results were obtained from three independent ex-
periments. Columns: mean relative densitometric intensities; error bars: ±SD; using two-tailed Student’s t-test, * P<0.05 versus control group.  
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Figure 7  NF-B expression in the nucleus treated with 1 mol/L nicotine 
for 24 h (b), 48 h (c) and 72 h (d) were increased significantly in Tca8113 
cells compared to nicotine-untreated cells (a), which indicated that NF-B 
was activated and translocated from cytoplasm to nucleus. 
untreated cells, which indicated that NF-B was activated 
and translocated from cytoplasm to nucleus.   
3  Discussion  
Epidemiologic studies have shown that tobacco is the pri-
mary etiological factor of OSCC [17]. Nicotine, as a source 
of exogenous oxidative stress, can elevate ROS level and 
cause DNA strand breakage, protein cross-linking, and lipid 
peroxidation, which can induce cell oxidative damage and 
promote oncogenesis [18]. Cultures of human gingival fi-
broblasts exposed to nicotine exhibited an increase in ROS- 
induced oxidative stress and conferred protection against 
DNA injury by the antioxidants NAC and CAT. In the cur-
rent study, both ROS levels and expression of Prx 1 were 
increased after nicotine treatment of a human OSCC cell 
line indicating that Prx 1 may play an important role in to-
bacco-associated OSCC. An increase in oxidative stress was 
also observed in colon cancer cells, after exposure to nico-
tine [16].  
Excessive ROS may result in oxidative stress leading to 
DNA injury, the formation of hydroperoxides from cell 
membrane phospholipids plays a key role in cellular dam-
age resulting from the action of ROS [19–21]. The Prx gene 
family plays an antioxidant role through their peroxidase 
activity removing extra hydrogen peroxide and organic hy-
droperoxides [22]. Prxs are thiol-specific antioxidant en-
zymes, a major common function of which is the degrada-
tion of hydrogen peroxide to remove extra ROS [23]. Prx 1 
which is the most abundant and ubiquitous Prx, plays an 
important role in protecting cells against oxidants [24]. 
Other studies have shown that Prx 1 is overly expressed in 
numerous human malignant tumors including lung, breast, 
and pancreatic cancers. Yanagawa et al. [25] found that Prx 
1 was overly expressed in 79% of the OSCC specimens 
examined by immunohistochemistry, whereas Neumann et 
al. [26] reported that overexpression of Prx 1 was associated 
with oxidative stress.  
NF-B is a nucleus transcription factor which plays im-
portant roles in a number of pathological conditions, for 
example oxidative stress. The activity of NF-B is primarily 
regulated by interaction with inhibitory IB proteins. In 
most cells, NF-B is present as a latent, inactive, IB-bound 
complex in the cytoplasm. When a cell is stimulated NF-B 
rapidly enters the nucleus and activates downstream gene 
expression [27]. In oxidative stress, ROS have various in-
hibitory or stimulatory roles in NF-B signaling. NF-B 
plays a major role in regulating the amount of ROS in the 
cell and regulates downstream transcriptional antioxidant 
and pro-oxidant targets [28]. One of the most important 
ways in which NF-B activity influences ROS levels is via 
increased expression of antioxidant proteins. Crosstalk from 
NF-B to JNK is known to prevent sustained JNK activa-
tion and thus prevents cell death through both apoptosis and 
necrosis [29]. GST  is up-regulated by oxidative stress 
through NF-B. GST  is a phase II enzyme that catalyzes 
the reaction of the GSH thiolate to toxic electrophilic com-
pounds, eliminate ROS or reactive carcinogens by excretion 
machinery. It is also proposed to repair the damage from 
oxidative stress. Disruption of the gene encoding GST  in 
HCT116 cells showed that GSTP1 protects HCT116 cells 
from oxidative stress and resultant apoptosis under growth- 
limiting conditions [12].     
Radiation-induced cytotoxicity is mediated primarily by 
the generation of ROS and ROS-driven oxidative stress. Prx 1 
exhibits a protective effect in tumor cells through enhancing 
clonogenic survival of irradiated cells against oxidative stress 
in lung cancer [30]. Overexpression of Prx 1 enhances the 
clonogenic survival of irradiated cells and suppresses ionizing 
radiation-induced JNK activation and apoptosis. The peroxi-
dase activity of Prx 1, however, is not essential for inhibit-
ing JNK activation. The latter effect is mediated through its 
interaction with the GST -JNK complex, thereby prevent-
ing JNK release from the complex [10]. 
In our previous studies, we observed an up-regulation of 
Prx1 and GST  in Tca8113 cells when compared to an oral 
precancerous cell line, DOK, by DNA microarray and im-
munohistochemistry [13]. In the current investigation, both 
mRNA and protein expression of Prx 1 and GST  were 
induced by nicotine in Tca8113 cells. A possible mecha-
nism leading to Prx 1 and GST  over-expression is likely 
due to the induction of ROS by nicotine. NF-κB expression 
increased in Tca8113 cell nucleus treated with 1 mol/L 
nicotine indicates that NF-B is activated by nicotine in-
duced oxidative stress, translocates from cytoplasm to nu-
cleus, interactes with Prx 1 which is overexpressed in nu-
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cleus and makes downstream transcriptional pathway acti-
vation, thereby regulates cell proliferation and apoptosis. 
The results suggest that Prx 1 is associated with tobac-
co-induced oxidative stress involved in OSCC and may 
serve as a new biomarker in OSCC. All findings might ena-
ble the development of new, more targeted approaches to 
treatment of oral cancers.  
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